Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2002
Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuriaPriscilla Kincaid-Smith, Kenneth Fairley, David PackhamNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 15, 2004
Dual blockade of the renin-angiotensin system compared with a 50% increase in the dose of angiotensin-converting enzyme inhibitor: effects on proteinuria and blood pressurePriscilla Kincaid-Smith, Kenneth F Fairley, David PackhamScandinavian Journal of Urology and Nephrology|December 26, 2009
Effect of pravastatin on kidney function and urinary protein excretion in autosomal dominant polycystic kidney diseaseRobert G Fassett, Jeff S Coombes, David Packham, et al.Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|February 25, 2012
Alopecia areata in two black Angus cowsBeth A Valentine, Robert J Bildfell, David Packham, et al.JAMA|November 18, 2014
Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trialMikhail Kosiborod, Henrik S Rasmussen, Philip Lavin, et al.Nephron|December 23, 2014
Pyridoxamine dihydrochloride in diabetic nephropathy (PIONEER-CSG-17): lessons learned from a pilot studyJamie P Dwyer, Barbara A Greco, Kausik Umanath, et al.European Heart Journal|March 23, 2011
Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trialsFrank A Holtkamp, Dick de Zeeuw, Pieter A de Graeff, et al.American Journal of Nephrology|June 7, 2014
Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Scott A Reisman, George L Bakris, et al.Kidney International|August 5, 2019
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney diseasePeter Rossing, Geoffrey A Block, Melanie P Chin, et al.Pageof 2